I like this point in the presentation on slide 18 :
"Philips & PainChek collaborative clinical study on reducing the risk of a delirium to commence post COVID-19 lock down",
and
"PainChek integration with hospital patient monitoring systems in review – value add to existing vital signs & can provide early warning of patient deterioration"
Also suggests indicative pricing for the infant app: $10/month with a net after app store commissions of $7/month. So with a 0.1% global market share, makes it annualised revenue of $33.6 million for that app alone. Let me repeat that 0.1% global market share!
Next two years are huge.
PainChek General Discussion, page-16704
-
- There are more pages in this discussion • 3,709 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
-0.003(8.33%) |
Mkt cap ! $53.98M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.6¢ | 3.3¢ | $91.67K | 2.719M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 187734 | 3.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 885331 | 1 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| PCK (ASX) Chart |